Pharma Patents in the Pandemic

In 2020, the number of international patent applications filed via WIPO continued to grow amid the COVID-19 pandemic, and currently there is a noticeable renewed interest in vaccine and antibody-related patents.

In this article, European Patent Attorney Ylva Skoglösa looks back at the past 15 months where pharma patents have gained increased attention.

 

Pharma Patents in the Pandemic